Showing results (11-20 of 173) with videos related to
Sort By:
Pageof 18
Annals of the Rheumatic Diseases|March 6, 2007
Assessment of the 2006 revised antiphospholipid syndrome classification criteriaMala Kaul, Doruk Erkan, Lisa Sammaritano, et al.Arthritis and Rheumatism|November 6, 2012
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndromeDoruk Erkan, JoAnn Vega, Glendalee Ramón, et al.Clinical and Experimental Rheumatology|September 12, 2013
Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patientsElizabeth Kozora, Doruk Erkan, Lening Zhang, et al.Current Rheumatology Reports|September 10, 2002
The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategiesDoruk ErkanTurkish Journal of Haematology : Official Journal of Turkish Society of Haematology|January 29, 2024
Antiphospholipid Syndrome: To Classify or Not to Classify?Doruk ErkanAutoimmunity Reviews|December 2, 2006
Therapeutic and prognostic considerations in catastrophic antiphospholipid syndromeDoruk ErkanArthritis and Rheumatism|June 30, 2007
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individualsDoruk Erkan, Melanie J Harrison, Roger Levy, et al.Current Rheumatology Reports|September 12, 2003
New insights into pregnancy-related complications in systemic lupus erythematosusDoruk Erkan, Lisa SammaritanoCurrent Rheumatology Reports|November 25, 2010
Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?Medha Barbhaiya, Doruk ErkanClinical Immunology (Orlando, Fla.)|March 7, 2018
Treatment of antiphospholipid syndrome beyond anticoagulationChrisanna Dobrowolski, Doruk ErkanPageof 18